Advertisement

Picture EBD Group World of Partnering Opportunities 650x100px
Organisation › Details

Inotrem S.A.

Inotrem S.A. is a biotechnology company specialized in immunotherapy for acute and chronic inflammatory syndromes. The company has developed a new concept of immunomodulation that targets the TREM-1 pathway to control unbalanced inflammatory responses. Through its proprietary technology platform, Inotrem has developed the first-in-class TREM-1 inhibitor, LR12 (nangibotide), with potential applications in a number of therapeutic indications such as septic shock and myocardial infarction. In parallel, Inotrem has also launched another program to develop a new therapeutic modality targeting chronic inflammatory diseases. The company was founded in 2013 by Dr. Jean-Jacques Garaud, a former head of research and early development at the Roche Group, Prof. Sébastien Gibot and Dr. Marc Derive. Inotrem is supported by leading European and North American investors. *

 

Period Start 2013-03-08 established
Products Industry anti-inflammatory drug
  Industry 2 peptide-based drug
Person Person Garaud, Jean-Jacques (Inotrem 201403 CEO before Roche –201206 Global Head pRED)
     
Region Region Paris
  Country France
  Street 54 rue de Ponthieu
  City 75008 Paris
  Tel +33-9-6681-7900
    Address record changed: 2024-01-05
     
Basic data Employees n. a.
     
    * Document for »About Section«: Inotrem S.A.. (9/12/19). "Press Release: Inotrem Announces €39 Million Series B Financing to Develop First-In-Class Immunology Therapeutics". Paris.
     
   
Record changed: 2024-02-12

Advertisement

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px

More documents for Inotrem S.A.


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture Berlin Partner Cardiovascular Health in Berlin-Brandenburg 650x300px




» top